Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

8R5T

Crystal structure of NDM-1 in complex with benzobisheterocycle compound 14.

Summary for 8R5T
Entry DOI10.2210/pdb8r5t/pdb
DescriptorMetallo-beta-lactamase type 2, [(1~{R},3~{a}~{R})-1,3,3~{a},4-tetrahydro-[1,3]thiazolo[3,4-a]benzimidazol-1-yl]methanethiol, ZINC ION, ... (5 entities in total)
Functional Keywordsmetallo-beta-lactamase, inhibitor, antimicrobial protein
Biological sourceKlebsiella pneumoniae
Total number of polymer chains2
Total formula weight52230.01
Authors
Hinchliffe, P.,Spencer, J. (deposition date: 2023-11-17, release date: 2024-04-10)
Primary citationVillamil, V.,Rossi, M.A.,Mojica, M.F.,Hinchliffe, P.,Martinez, V.,Castillo, V.,Saiz, C.,Banchio, C.,Macias, M.A.,Spencer, J.,Bonomo, R.A.,Vila, A.,Moreno, D.M.,Mahler, G.
Rational Design of Benzobisheterocycle Metallo-beta-Lactamase Inhibitors: A Tricyclic Scaffold Enhances Potency against Target Enzymes.
J.Med.Chem., 67:3795-3812, 2024
Cited by
PubMed Abstract: Antimicrobial resistance is a global public health threat. Metallo-β-lactamases (MBLs) inactivate β-lactam antibiotics, including carbapenems, are disseminating among Gram-negative bacteria, and lack clinically useful inhibitors. The evolving bisthiazolidine (BTZ) scaffold inhibits all three MBL subclasses (B1-B3). We report design, synthesis, and evaluation of BTZ analogues. Structure-activity relationships identified the BTZ thiol as essential, while carboxylate is replaceable, with its removal enhancing potency by facilitating hydrophobic interactions within the MBL active site. While the introduction of a flexible aromatic ring is neutral or detrimental for inhibition, a rigid (fused) ring generated nM benzobisheterocycle (BBH) inhibitors that potentiated carbapenems against MBL-producing strains. Crystallography of BBH:MBL complexes identified hydrophobic interactions as the basis of potency toward B1 MBLs. These data underscore BTZs as versatile, potent broad-spectrum MBL inhibitors (with activity extending to enzymes refractory to other inhibitors) and provide a rational approach to further improve the tricyclic BBH scaffold.
PubMed: 38373290
DOI: 10.1021/acs.jmedchem.3c02209
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.58 Å)
Structure validation

227561

数据于2024-11-20公开中

PDB statisticsPDBj update infoContact PDBjnumon